Proposed CMS rule would streamline Medicaid, CHIP enrollment
The proposal comes as states begin to notify Medicaid beneficiaries about potential losses of coverage due to the impending end of the COVID-19 public health emergency.
New rural hospital designation still needs tweaks and more flexibility, stakeholders say
Rural providers are weighing whether to switch to a new payment model as federal regulators aim to curb hospital closures.
Walgreens completes majority stake acquisition in CareCentrix
Walgreens announced it planned to acquire CareCentrix in October as the retailer looks to bolster its Walgreens Health business segment.
Scan Group’s deal-maker, Binoy Bhansali, dishes on the importance of creating ‘competitive moats’ to accelerate growth
The vice president of corporate development explains the strategy behind the group’s latest investments and how it will help the insurance unit compete in the long term.
Funds for free COVID-19 vaccines could run out as early as January, HHS says
The commercial market for COVID-19 vaccinations could be similar to that for seasonal flu shots and other vaccines, the department said.
FDA clears updated COVID-19 boosters from Pfizer, Moderna
The new shots, which are designed to better target circulating strains of omicron, could be available within days. Advisers to the CDC are set to meet later this week.
Oscar loses big tech customer amid platform implementation snags
Health First’s decision to terminate their agreement — Oscar’s first full-service tech deal — will cause the insurtech to lose out on up to $60 million in revenue this year.
Higher staffing costs drive Cleveland Clinic’s Q2 loss
The health system said salaries, wages and benefits swelled 16% from a year ago.
Monkeypox vaccine supply woes easing, federal public health officials say
The HHS so far has made over 1 million vials available to jurisdictions, “which is nearly enough to reach the entire population that’s most at risk,” Secretary Xavier Becerra said during a call with reporters Tuesday.
FTC sues data broker Kochava for selling data that could track clinic visits
Kochava called the lawsuit “frivolous” and said the FTC was operating under a “fundamental misunderstanding” of its data marketplace business.